To support the information technology (IT) infrastructure and the quality management system (QMS), the center for drug evaluation and research (CDER) needs IT support to ensure day-to-day operations…
Ended Awarded Last action
- Contract number
- 75F40120F19117
- Awardee
-
Brillient Corporation UEI MMAVC7UGLJ78
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $397,843
Award facts
- Contract value 100% obligated
- $397,842.98 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- St. Louis, MO 63110, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$14,243 | |
| Exercise an Option | $207,929 | |
| Original award | $204,156 |
About this award
This contract was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Brillient Corporation, a management, technology, and business process firm, to provide Information Technology (IT) support and Quality Management System (QMS) services to the FDA's Center for Drug Evaluation and Research (CDER). The contract, which is a Blanket Purchase Agreement (BPA) Call under the Professional Services Schedule (PSS) contract vehicle, has a potential value of $397,842.98 and is for a time and materials pricing type. The contract does not have a set-aside designation and was awarded on April 27, 2020, with a completion date of July 12, 2022. As a prime contractor, Brillient has delivered various IT, engineering, consulting, and administrative support services to federal agencies like the Department of Health and Human Services, Department of Homeland Security, and National Institutes of Health.
Description
To support the information technology (IT) infrastructure and the quality management system (QMS), the center for drug evaluation and research (CDER) needs IT support to ensure day-to-day operations of the pharmaceutical characterization and quality
Quick answers
Who was awarded contract 75F40120F19117?
75F40120F19117 was awarded to Brillient Corporation by Food and Drug Administration (Department of Health and Human Services) on April 27, 2020.
How much is contract 75F40120F19117 worth?
The government has obligated $397,843 on 75F40120F19117.
Is contract 75F40120F19117 an order under another contract?
Yes. 75F40120F19117 is a BPA call under GS00F012BA-HHSF223201810005B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40120F19117 competed?
The extent of competition for 75F40120F19117 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award